Cigna-Express Scripts deal clears regulatory hurdles in California, New York

Cigna and Express Scripts gained approval from California and New York regulators to move forward with their $67 billion merger, according to filings with the Securities and Exchange Commission.

Advertisement

California and New York regulators both issued their approvals Dec. 13. Cigna and Express Scripts said New Jersey is the last state from which the companies need approval to continue with the transaction.

The health insurer and pharmacy benefits manager still expect their deal to close by the end of 2018, despite missing an original Dec. 8 deadline. The companies’ new merger termination date is June 8, 2019, according to a Nov. 21 Securities and Exchange Commission filing.

More articles on payers:
CMS’ final rule on risk adjustment payments: 3 things to know
BCBS of Wyoming customers overcharged due to banking error
ACA plan enrollment falls 11%: 3 things to know

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Transactions & Valuation Issues

Advertisement

Comments are closed.